 |
| Global Antibodies Market Size |
Antibodies are proteins produced by B cells that recognize and help eliminate foreign objects like bacteria and viruses. Monoclonal antibodies target specific proteins on the membranes or in the cytosol of targeted cells. They find increasing application in targeted cancer therapies and autoimmune disease treatment. Monoclonal antibodies confer high specificity and minimal toxicity compared to conventional therapies. Promising clinical trial results for conditions like rheumatoid arthritis, Crohn's disease, psoriasis and various cancers have spurred their adoption.
The global
antibodies market is estimated to be valued at US$ 224083.5 Mn in 2023 and is expected to exhibit a CAGR of 16.% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key trends:
The growing popularity of targeted therapies is one of the key trends driving
growth in the antibodies market. Monoclonal antibodies offer significant
advantages over traditional chemotherapy by selectively targeting cancer cells
while sparing healthy cells. This results in fewer side effects and improved
clinical outcomes. Promising pipeline candidates for cancers like lung cancer,
breast cancer and leukemia are garnering significant R&D investments from
key players. For example, Bain Capital has invested $100 million in Harmony
Biosciences’ pipeline drug for narcolepsy treatment. Such targeted funding is
accelerating the development of novel antibodies to treat various diseases more
effectively. This growing demand for safer and effective targeted therapies
will continue driving market revenues upwards over the forecast period.
Segment
Analysis
The global antibodies market is dominated by the monoclonal antibodies segment,
which accounts for around 80% of the total market share. Monoclonal antibodies
have seen increasing demand due to their high specificity and affinity towards
antigen detection. They are also more efficacious and have fewer side effects
than other antibody types.
Key Takeaways
Global
Antibodies Market Size is expected to witness high growth over the
forecast period of 2023 to 2030.
Regional
analysis: The North America region currently dominates the global antibodies
market and is expected to remain the highest revenue generating region during
the forecast period. This can be attributed to the rising prevalence of chronic
and infectious diseases, along with growing pharmaceutical R&D expenditure
in the region.
Key players: Key players operating in the antibodies market are Bose
Corporation, Beats Electronics, 3M, Audio-Technica Ltd, Panasonic Corporation,
Apple Inc., Bowers & Wilkins Group Ltd., GN Group, Harman International,
Inc., Sony Corporation, Logitech International S.A., Koninklijke Philips N.V.,
Pioneer Corporation, and Sennheiser Electronic GmbH & Co. KG.
Explore More Related Article On This
Topic: https://www.pressreleasebulletin.com/antibodies-market-trends/
Explore More Related Article On This
Topic: https://allmeaninginhindi.com/exploring-the-vital-world-of-intravenous-solutions-for-health-and-healing/